Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Gains from Investment Securities (2016 - 2025)

Viking Therapeutics (VKTX) has disclosed Gains from Investment Securities for 12 consecutive years, with $41000.0 as the latest value for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 99.9% year-over-year to $41000.0; the TTM value through Mar 2026 reached $42.0 million, down 50.02%, while the annual FY2025 figure was $5.1 million, 18669.74% up from the prior year.
  • Gains from Investment Securities hit $41000.0 in Q4 2025 for Viking Therapeutics, down from $5.2 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $42.1 million in Q1 2024 and bottomed at $2000.0 in Q2 2024.
  • Average Gains from Investment Securities over 5 years is $7.5 million, with a median of $473000.0 recorded in 2021.
  • Year-over-year, Gains from Investment Securities surged 11326.67% in 2023 and then tumbled 99.9% in 2025.
  • Viking Therapeutics' Gains from Investment Securities stood at $257056.0 in 2021, then tumbled by 88.33% to $30000.0 in 2022, then skyrocketed by 5613.33% to $1.7 million in 2023, then soared by 2349.82% to $42.0 million in 2024, then crashed by 99.9% to $41000.0 in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $41000.0, $5.2 million, and $42.0 million for Q4 2025, Q3 2025, and Q4 2024 respectively.